M
Magnus Unemo
Researcher at Örebro University
Publications - 465
Citations - 22073
Magnus Unemo is an academic researcher from Örebro University. The author has contributed to research in topics: Neisseria gonorrhoeae & Antibiotic resistance. The author has an hindex of 62, co-authored 418 publications receiving 17623 citations. Previous affiliations of Magnus Unemo include World Health Organization.
Papers
More filters
Journal ArticleDOI
Appropriate Time for Test-of-Cure when Diagnosing Gonorrhoea with a Nucleic Acid Amplification Test
Stig Ove Hjelmevoll,Merethe Elise Olsen,Johanna U. Ericson Sollid,Håkon Haaheim,Kjetil K. Melby,Harald Moi,Magnus Unemo,Vegard Skogen +7 more
TL;DR: Investigation of the appropriate time for test-of-cure (TOC) when NAATs are used for diagnosis of gonorrhoea found that TOC can be performed 2 weeks after treatment when ciprofloxacin is used fordiagnosis.
Journal ArticleDOI
Syphilis epidemiology in 1994-2013, molecular epidemiological strain typing and determination of macrolide resistance in Treponema pallidum in 2013-2014 in Tuva Republic, Russia.
Rafil Khairullin,Denis Vorobyev,Andrey Obukhov,Ural-Herel Kuular,A. A. Kubanova,Alexey A. Kubanov,Magnus Unemo +6 more
TL;DR: This is the first internationally published typing study regarding T. pallidum in Russia, performed in the Tuva Republic with the highest syphilis incidence in Russia and for the first time, macrolide‐resistant syphilis was described in Russia.
Journal ArticleDOI
Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.
Fadi E. El-Rami,Ryszard A. Zielke,Teodora Wi,Aleksandra E. Sikora,Aleksandra E. Sikora,Magnus Unemo +5 more
TL;DR: These investigations provide a reference proteomics data bank for gonococcal vaccine and AMR research endeavors, which enables microbiological, clinical, or epidemiological projects and enhances the utility of the WHO reference strains.
Journal ArticleDOI
Propionibacterium acnes as an etiological agent of arthroplastic and osteosynthetic infections – Two cases with specific clinical presentation including formation of draining fistulae
TL;DR: Potypic and genetic characterisation of the isolates clearly emphasizes the significance of P. acnes as an etiological agent of implant infections, which are insidious with delayed presentation of symptoms and may have been overlooked because of the frequent use of suboptimal culture procedures.
Journal ArticleDOI
Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.
TL;DR: Gentamicin 240 mg plus azithromycin 2 g is an effective alternative for treatment of extragenital gonorrhoea and was not more painful than ceftriaxone according to the visual analog scale.